These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30738994)

  • 21. Identification of molecular network of gut-brain axis associated with neuroprotective effects of PPARδ-ligand erucic acid in rotenone-induced Parkinson's disease model in zebrafish.
    Ünal İ; Cansız D; Sürmen MG; Sürmen S; Sezer Z; Beler M; Üstündağ ÜV; Güzel E; Alturfan AA; Emekli-Alturfan E
    Eur J Neurosci; 2023 Feb; 57(4):585-606. PubMed ID: 36564343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A mixture of oleic, erucic and conjugated linoleic acids modulates cerebrospinal fluid inflammatory markers and improve somatosensorial evoked potential in X-linked adrenoleukodystrophy female carriers.
    Cappa M; Bizzarri C; Petroni A; Carta G; Cordeddu L; Valeriani M; Vollono C; De Pasquale L; Blasevich M; Banni S
    J Inherit Metab Dis; 2012 Sep; 35(5):899-907. PubMed ID: 22189598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A two-year trial of oleic and erucic acids ("Lorenzo's oil") as treatment for adrenomyeloneuropathy.
    Aubourg P; Adamsbaum C; Lavallard-Rousseau MC; Rocchiccioli F; Cartier N; Jambaqué I; Jakobezak C; Lemaitre A; Boureau F; Wolf C
    N Engl J Med; 1993 Sep; 329(11):745-52. PubMed ID: 8350883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lorenzo's oil may help to prevent ALD symptoms.
    Senior K
    Lancet Neurol; 2002 Dec; 1(8):468. PubMed ID: 12849323
    [No Abstract]   [Full Text] [Related]  

  • 25. Therapy of X-linked adrenoleukodystrophy.
    Semmler A; Köhler W; Jung HH; Weller M; Linnebank M
    Expert Rev Neurother; 2008 Sep; 8(9):1367-79. PubMed ID: 18759549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy.
    Kemp S; Valianpour F; Denis S; Ofman R; Sanders RJ; Mooyer P; Barth PG; Wanders RJ
    Mol Genet Metab; 2005 Feb; 84(2):144-51. PubMed ID: 15670720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A hierarchical Bayesian approach for combining pharmacokinetic/pharmacodynamic modeling and Phase IIa trial design in orphan drugs: Treating adrenoleukodystrophy with Lorenzo's oil.
    Basu C; Ahmed MA; Kartha RV; Brundage RC; Raymond GV; Cloyd JC; Carlin BP
    J Biopharm Stat; 2016; 26(6):1025-1039. PubMed ID: 27547896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipoid pneumonia as a complication of Lorenzo's oil therapy in a patient with adrenoleukodystrophy.
    Majori M; Scarascia A; Anghinolfi M; Pisi R; Gnetti L; Casalini AG
    J Bronchology Interv Pulmonol; 2014 Jul; 21(3):271-3. PubMed ID: 24992138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dietary treatment for X-linked adrenoleukodystrophy: is "Lorenzo's oil" useful?
    Prieto Tenreiro A; Penacho Lázaro MÁ; Andrés Celda R; Fernández Fernández M; González Mateo C; Díez Hernández A
    Endocrinol Nutr; 2013 Jan; 60(1):37-9. PubMed ID: 22622158
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of X-linked adrenoleukodystrophy with Lorenzo's oil.
    Moser HW
    J Neurol Neurosurg Psychiatry; 1999 Sep; 67(3):279-80. PubMed ID: 10449544
    [No Abstract]   [Full Text] [Related]  

  • 31. Positive effects with Lorenzo's oil.
    Siva N
    Lancet Neurol; 2005 Sep; 4(9):529. PubMed ID: 16136703
    [No Abstract]   [Full Text] [Related]  

  • 32. [Adrenoleukodystrophy: Lorenzo's Oil].
    Yamawaki T
    Brain Nerve; 2022 Dec; 74(12):1354-1357. PubMed ID: 36503132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fish oil feeding attenuates neuroinflammatory gene expression without concomitant changes in brain eicosanoids and docosanoids in a mouse model of Alzheimer's disease.
    Hopperton KE; Trépanier MO; James NCE; Chouinard-Watkins R; Bazinet RP
    Brain Behav Immun; 2018 Mar; 69():74-90. PubMed ID: 29109025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nervonic acid and demyelinating disease.
    Sargent JR; Coupland K; Wilson R
    Med Hypotheses; 1994 Apr; 42(4):237-42. PubMed ID: 8072429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lorenzo's oil and thrombocytopenia in patients with adrenoleukodystrophy.
    Zinkham WH; Kickler T; Borel J; Moser HW
    N Engl J Med; 1993 Apr; 328(15):1126-7. PubMed ID: 8455677
    [No Abstract]   [Full Text] [Related]  

  • 36. Adrenoleukodystrophy: molecular genetics, pathology, and Lorenzo's oil.
    Moser HW; Powers JM; Smith KD
    Brain Pathol; 1995 Jul; 5(3):259-66. PubMed ID: 8520725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lorenzo's oil: advances in the treatment of neurometabolic disorders.
    Ferri R; Chance PF
    Arch Neurol; 2005 Jul; 62(7):1045-6. PubMed ID: 16009756
    [No Abstract]   [Full Text] [Related]  

  • 38. Lorenzo's oil therapy of adrenoleukodystrophy.
    DiGregorio VY; Schroeder DJ
    Ann Pharmacother; 1995 Mar; 29(3):312-3. PubMed ID: 7606079
    [No Abstract]   [Full Text] [Related]  

  • 39. More on Lorenzo's oil.
    Odone A; Odone M
    N Engl J Med; 1994 Jun; 330(26):1904-5. PubMed ID: 8196741
    [No Abstract]   [Full Text] [Related]  

  • 40. Lorenzo's oil: a reassessment.
    Poulos A; Robertson EF
    Med J Aust; 1994 Mar; 160(6):315-7. PubMed ID: 8133809
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.